Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Denali Therapeutics
DNLI
$1.91B
| $26.1M | 0.01% |
1,080,950
+98,431
| +10% | +$2.38M |
|
1302
Xencor
XNCR
$660M
| $26.1M | 0.01% |
805,887
+74,322
| +10% | +$2.41M |
|
1303
Agnico Eagle Mines
AEM
$77B
| $26M | 0.01% |
407,869
+30,265
| +8% | +$1.93M |
|
1304
AeroVironment
AVAV
$13.6B
| $26M | 0.01% |
326,510
+8,674
| +3% | +$691K |
|
|
BMCH
1305
DELISTED
BMC Stock Holdings, Inc
BMCH
| $26M | 0.01% |
1,033,612
+18,319
| +2% | +$461K |
|
1306
Rambus
RMBS
$10.5B
| $26M | 0.01% |
1,707,593
+59,443
| +4% | +$904K |
|
1307
Adaptive Biotechnologies
ADPT
$1.95B
| $25.9M | 0.01% |
536,132
+68,896
| +15% | +$3.33M |
|
1308
NETSCOUT
NTCT
$1.82B
| $25.9M | 0.01% |
1,013,782
-7,138
| -0.7% | -$182K |
|
1309
Appian
APPN
$2.33B
| $25.8M | 0.01% |
504,355
+5,510
| +1% | +$282K |
|
|
SAGE
1310
DELISTED
Sage Therapeutics
SAGE
| $25.8M | 0.01% |
620,400
+25,158
| +4% | +$1.05M |
|
|
CIM
1311
Chimera Investment
CIM
$1.13B
| $25.8M | 0.01% |
894,514
+166,688
| +23% | +$4.81M |
|
1312
Fluor
FLR
$6.52B
| $25.7M | 0.01% |
2,131,201
+485,030
| +29% | +$5.86M |
|
1313
SPX Corp
SPXC
$9.14B
| $25.7M | 0.01% |
625,635
+15,325
| +3% | +$631K |
|
1314
Jack in the Box
JACK
$354M
| $25.7M | 0.01% |
346,783
-25,847
| -7% | -$1.91M |
|
|
ILPT
1315
Industrial Logistics Properties Trust
ILPT
$423M
| $25.7M | 0.01% |
1,249,864
+280,758
| +29% | +$5.77M |
|
1316
Albany International
AIN
$1.66B
| $25.6M | 0.01% |
436,648
+6,276
| +1% | +$368K |
|
1317
Corcept Therapeutics
CORT
$7.92B
| $25.6M | 0.01% |
1,523,954
+44,693
| +3% | +$752K |
|
1318
TripAdvisor
TRIP
$2.15B
| $25.6M | 0.01% |
1,347,989
-20,120
| -1% | -$382K |
|
1319
Federal Signal
FSS
$7.6B
| $25.6M | 0.01% |
861,654
+29,497
| +4% | +$877K |
|
|
VRE
1320
Veris Residential
VRE
$1.43B
| $25.6M | 0.01% |
1,673,929
+16,169
| +1% | +$247K |
|
|
STL
1321
DELISTED
Sterling Bancorp
STL
| $25.6M | 0.01% |
2,181,917
-242,689
| -10% | -$2.84M |
|
1322
Dana Inc
DAN
$2.68B
| $25.5M | 0.01% |
2,094,673
+61,528
| +3% | +$750K |
|
|
MNR
1323
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $25.5M | 0.01% |
1,760,332
+403,430
| +30% | +$5.85M |
|
|
ROIC
1324
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $25.5M | 0.01% |
2,251,242
+52,770
| +2% | +$598K |
|
1325
Essential Properties Realty Trust
EPRT
$5.93B
| $25.5M | 0.01% |
1,716,007
+392,023
| +30% | +$5.82M |
|